David Hafler shares his insights and highlights from ECTRIMS-ACTRIMS 2017.
1. What have been the most significant recent developments in MS? (0:05)
2. Discuss the current unmet needs and/or the challenges you face as an MS specialist (0:47)
3. What are the most promising areas of MS research? (01:58)
4. Which presentations/data at ECTRIMS-ACTRIMS have interested you the most? (02:49)
5. Do you have a message for young MS specialists in Europe/US? (03:22)
Speaker disclosures: David Hafler serves as a consultant to BioHaven Pharma, Bristol-Myers Squibb, EMD Serono, Genentech, MedImmune, Mylan Pharmaceuticals and ProClara Bioscience.
Filmed at the 7th Joint ECTRIMS-ACTRIMS Meeting, Paris, France, October 2017.
